Haemonetics Corporation (HAE)

Haemonetics Stock Forecast

Stock Price Forecast

The 9 analysts that cover Haemonetics stock have a consensus rating of "Strong Buy" and an average price target of $79.22, which forecasts a 18.05% increase in the stock price over the next year. The lowest target is $62 and the highest is $100.

Price Target: $79.22 (+18.05%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$62	$79.22	$78	$100
Change	-7.61%	+18.05%	+16.23%	+49.01%

Analyst Ratings

The average analyst rating for Haemonetics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	4	5	4	2	2	3
Buy	4	4	5	5	5	5
Hold	2	1	2	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	11	8	8	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mike Matson Needham	Needham	Strong Buy Maintains $68 → $78	Strong Buy	Maintains	$68 → $78	+16.23%	Nov 7, 2025
Marie Thibault BTIG	BTIG	Strong Buy Maintains $85 → $88	Strong Buy	Maintains	$85 → $88	+31.13%	Nov 6, 2025
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $86	Buy	Maintains	$86	+28.15%	Oct 21, 2025
Joanne Wuensch Citigroup	Citigroup	Strong Buy Maintains $78 → $64	Strong Buy	Maintains	$78 → $64	-4.63%	Oct 7, 2025
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $86	Buy	Maintains	$86	+28.15%	Sep 23, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.31B

Decreased by -3.96%

from 1.36B

Revenue Next Year

1.39B

Increased by 6.35%

from 1.31B

EPS This Year

4.87

Increased by 47.26%

from 3.31

EPS Next Year

5.52

Increased by 13.15%

from 4.87

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Apr 3, 2021	Apr 2, 2022	Apr 1, 2023	Mar 30, 2024	Mar 29, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	870.46M	993.20M	1.17B	1.31B	1.36B	1.31B	1.39B
Revenue Growth	-11.94%	14.10%	17.67%	12.01%	3.96%	-3.96%	6.35%
EPS	1.55	0.84	2.24	2.29	3.31	4.87	5.52
EPS Growth	4.73%	-45.81%	166.67%	2.23%	44.54%	47.26%	13.15%
Forward PE	-	-	-	-	-	13.77	12.17
No. Analysts	-	-	-	-	-	12	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	1.4B	1.5B
Avg	1.3B	1.4B
Low	1.2B	1.3B

Revenue Growth

Revenue Growth	2026	2027	2028
High	1.0%	13.8%
Avg	-4.0%	6.4%
Low	-8.3%	0.4%

EPS Forecast

EPS	2026	2027	2028
High	5.15	5.94
Avg	4.87	5.52
Low	4.64	5.09

EPS Growth

EPS Growth	2026	2027	2028
High	55.4%	21.9%
Avg	47.3%	13.1%
Low	40.0%	4.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.